TrialCancer prevention research (Philadelphia, Pa.)2023

Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.

Anne E O'Shea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.